Boxer Khelif reveals 'hormone treatments' before Paris Olympics

Weather - Sydney 9°C

Boxer Khelif reveals 'hormone treatments' before Paris Olympics

ECONOMY 04.02.2026

Boxer Khelif reveals 'hormone treatments' before Paris Olympics / Photo: © AFP/File

Olympic boxing champion Imane Khelif revealed in an interview with French sports daily L'Equipe that she had undergone hormone treatments to lower her testosterone levels ahead of the 2024 Games, but reaffirmed that she is not "transgender".

Change text size:

Khelif was embroiled in a gender row at the Paris Games where she won gold in the women's 66kg category.

"I have female hormones. And people don't know this, but I have taken hormone treatments to lower my testosterone levels for competitions," the 26-year-old Algerian said in the interview published Wednesday.

Khelif confirmed she has the SRY gene, located on the Y chromosome that indicates masculinity.

"Yes, and it's natural," she said, adding that she is "surrounded by doctors, a professor is monitoring me... For the Paris Games qualifying tournament, which took place in Dakar, I lowered my testosterone levels to zero".

Like Taiwan's Lin Yu-ting, who also won gold in another category at the Paris Games, Khelif found herself at the centre of a gender row that attracted comments from US President Donald Trump and "Harry Potter" author J.K. Rowling.

"I respect everyone, and I respect Trump. Because he is the President of the United States. But he cannot distort the truth. I am not a trans woman, I am a girl. I was raised as a girl, I grew up as a girl, the people in my village have always known me as a girl," Khelif said.

The boxer, who aims to compete in the 2028 Olympics in Los Angeles, knows that she will have to agree to mandatory gender testing imposed by World Boxing, a body recognised by the International Olympic Committee, and says she is ready.

"For the next Games, if I have to take a test, I will. I have no problem with that," she said.

"I've already taken this test. I contacted World Boxing, I sent them my medical records, my hormone tests, everything. But I haven't had any response. I'm not hiding, I'm not refusing the tests."

Khelif said it was for doctors and professors to "decide", but stated: "We all have different genetics, different hormone levels. I'm not transgender. My difference is natural. This is who I am. I haven't done anything to change the way nature made me. That's why I'm not afraid."

Khelif, who has not fought since the Paris Games, as World Boxing prevented her from participating in last year's tournament in the Netherlands because she had not undergone the newly introduced chromosome test, revealed she is awaiting a French professional boxing licence.

She said for her, it was "the logical next step", but added that did not mean she was giving up on competing in two year's time in LA.

"Not at all. I want to... become the first person in Algerian sport to successfully defend their Olympic title," she said.

F.Jackson--TNT

Featured

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Change text size:

The National Times - Boxer Khelif reveals 'hormone treatments' before Paris Olympics